Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP369304.RAt4uUsx8ChJgGya6oawtQkD876tIymUgFNzWPxVq2NsA130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369304.RAt4uUsx8ChJgGya6oawtQkD876tIymUgFNzWPxVq2NsA130_provenance.
• NP699019.RA1fJjIzgy5IaC6RJbxgeoTTEs1EQuImhn7TrDlkHitX4130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699019.RA1fJjIzgy5IaC6RJbxgeoTTEs1EQuImhn7TrDlkHitX4130_provenance.
• NP869358.RA9jsmrvHSvl4XWgI22ZBSYqDC9BYRBEjrFv7IF_6_kCw130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869358.RA9jsmrvHSvl4XWgI22ZBSYqDC9BYRBEjrFv7IF_6_kCw130_provenance.
• NP978608.RAfddHC9Gb4_C30oFYY1czJ4eMcRSRtYcps5PDxCRZsyU130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978608.RAfddHC9Gb4_C30oFYY1czJ4eMcRSRtYcps5PDxCRZsyU130_provenance.
• NP781518.RAplPhtM1TUYHcJnvKLchVCieyzh7NcA7OuKo0f_AEh3c130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781518.RAplPhtM1TUYHcJnvKLchVCieyzh7NcA7OuKo0f_AEh3c130_provenance.
• NP873069.RADWCf_L-7fmnPH9Zdse5Q3rn0vHhycMJFqDbVC9YFya8130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873069.RADWCf_L-7fmnPH9Zdse5Q3rn0vHhycMJFqDbVC9YFya8130_provenance.
• NP873262.RABQNUmXqQZorkAHm8Oddflq-jwzaUK2EJFt0oGdDw56w130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873262.RABQNUmXqQZorkAHm8Oddflq-jwzaUK2EJFt0oGdDw56w130_provenance.
• NP335571.RAVsMWA8xSuEQA15sfSeRGChoHNMOP1eiBKkwRSI7z6dI130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335571.RAVsMWA8xSuEQA15sfSeRGChoHNMOP1eiBKkwRSI7z6dI130_provenance.
• NP335574.RAXQWG7Ox5XF5j8mqvK4XKfM9z75e0cLxF9g8frlx3iVk130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335574.RAXQWG7Ox5XF5j8mqvK4XKfM9z75e0cLxF9g8frlx3iVk130_provenance.
• NP335575.RAdSnWuJlI_6reL_FJCb6HEvup4oWXrN9DZNf3KU4zFeo130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335575.RAdSnWuJlI_6reL_FJCb6HEvup4oWXrN9DZNf3KU4zFeo130_provenance.
• NP335578.RAXZx-rjnlgPqzYb-rlLFq0x49kqAR_VNAo0iSGIh2S6Q130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335578.RAXZx-rjnlgPqzYb-rlLFq0x49kqAR_VNAo0iSGIh2S6Q130_provenance.
• NP606089.RACxVMK0BrUBW81aCWpbK0CyuKWAHSb5MzrgOc7g2S6tE130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606089.RACxVMK0BrUBW81aCWpbK0CyuKWAHSb5MzrgOc7g2S6tE130_provenance.
• NP978404.RAsNtF-99gpHqcb2iPx9pM-kigqRuD47bwn1ykQNEX464130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978404.RAsNtF-99gpHqcb2iPx9pM-kigqRuD47bwn1ykQNEX464130_provenance.
• NP335568.RAkEM7bfSu1L8tQz7ACmNgq_sxu6fjUxtkDqs_OlTcIkk130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335568.RAkEM7bfSu1L8tQz7ACmNgq_sxu6fjUxtkDqs_OlTcIkk130_provenance.
• NP335573.RAqmBO5i54n6blGndhcBoT5ligNKhexwrHr0ZaQPVVxW0130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335573.RAqmBO5i54n6blGndhcBoT5ligNKhexwrHr0ZaQPVVxW0130_provenance.
• NP335579.RAjiYheiT2nsNZoIKc-hYaL9QOx7kqtmKH2v8mQBfpyQk130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335579.RAjiYheiT2nsNZoIKc-hYaL9QOx7kqtmKH2v8mQBfpyQk130_provenance.
• NP605867.RA817PIxtq6Tadu9IrXVUj3vgvt5FxwLO8sHoKFNSWUyc130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605867.RA817PIxtq6Tadu9IrXVUj3vgvt5FxwLO8sHoKFNSWUyc130_provenance.
• NP781315.RAwDMQKxl7Ci727VzJLiWA8MV2Nz9rtgzoikIdVP1nSoQ130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781315.RAwDMQKxl7Ci727VzJLiWA8MV2Nz9rtgzoikIdVP1nSoQ130_provenance.
• NP335565.RAIzN1bjR7dN7DYx5nBxE2os369UqHFBa2IUoptJZ7vpY130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335565.RAIzN1bjR7dN7DYx5nBxE2os369UqHFBa2IUoptJZ7vpY130_provenance.
• NP335566.RAG0iBB6uMyVAbvgktKKDK6mTARZx2RCoTCaQSxI5Gt8Y130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335566.RAG0iBB6uMyVAbvgktKKDK6mTARZx2RCoTCaQSxI5Gt8Y130_provenance.
• NP335577.RAPbuzA3ipii32PNwrfwZNRLLVT5yMPHMNoeMlZ7MZVjA130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335577.RAPbuzA3ipii32PNwrfwZNRLLVT5yMPHMNoeMlZ7MZVjA130_provenance.
• NP335580.RAFb9VuBUmznnOUAIU0mVq8vZehrpYYFAIYRzg8mgTW38130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335580.RAFb9VuBUmznnOUAIU0mVq8vZehrpYYFAIYRzg8mgTW38130_provenance.
• NP913894.RA3I_4YNdP1QTN0zghEo-vgF_OYFtEIJ5Kf5Tha4KjWj4130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913894.RA3I_4YNdP1QTN0zghEo-vgF_OYFtEIJ5Kf5Tha4KjWj4130_provenance.
• NP914127.RA17r2WBBUAUcSuqvPuN3AsSRs7171UNf5qujhvlzmZqQ130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914127.RA17r2WBBUAUcSuqvPuN3AsSRs7171UNf5qujhvlzmZqQ130_provenance.
• NP335569.RAw11bOCwvyru5tNLW6caVaUTQVVo7Ig2fZdurk1Vwo30130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335569.RAw11bOCwvyru5tNLW6caVaUTQVVo7Ig2fZdurk1Vwo30130_provenance.
• NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.
• NP335572.RA11KEXTfCX4W7mEoCbxqGUjKwLcRhRUi8Vqc1n2Rws8Q130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335572.RA11KEXTfCX4W7mEoCbxqGUjKwLcRhRUi8Vqc1n2Rws8Q130_provenance.
• NP335581.RAzz0WOie6owSrUlIcGpOg-Nvzq8oT0CIsqqPYbWFK5dc130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335581.RAzz0WOie6owSrUlIcGpOg-Nvzq8oT0CIsqqPYbWFK5dc130_provenance.